TG Therapeutics Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BLACKROCK, INC. | 02/12/2026 | 21.85 M | $651.30 M | 2.57% | 15.02% |
| VANGUARD GROUP INC | 01/29/2026 | 15.84 M | $472.22 M | 2.06% | 10.89% |
| STATE STREET CORP | 02/13/2026 | 8.48 M | $252.79 M | 4.68% | 5.83% |
| CLEARBRIDGE INVESTMENTS, LLC | 02/11/2026 | 3.45 M | $102.79 M | -25.76% | 2.37% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/09/2026 | 3.40 M | $101.48 M | -1.16% | 2.34% |
| SOLEUS CAPITAL MANAGEMENT, L.P. | 02/12/2026 | 3.14 M | $93.58 M | -18.35% | 2.16% |
| GOLDMAN SACHS GROUP INC | 03/25/2026 | 2.05 M | $61.14 M | 35.00% | 1.41% |
| CONGRESS ASSET MANAGEMENT CO /MA | 01/09/2026 | 1.92 M | $57.31 M | 100.00% | 1.32% |
| INVESCO LTD. | 02/19/2026 | 1.61 M | $47.99 M | 47.10% | 1.11% |
| HOOD RIVER CAPITAL MANAGEMENT LLC | 02/17/2026 | 1.58 M | $47.14 M | 1.83% | 1.09% |
| MORGAN STANLEY | 02/13/2026 | 1.50 M | $44.81 M | 20.45% | 1.03% |
| PICTET ASSET MANAGEMENT HOLDING SA | 01/29/2026 | 1.46 M | $43.55 M | -9.23% | 1.00% |
| NORTHERN TRUST CORP | 02/17/2026 | 1.42 M | $42.32 M | -5.47% | 0.98% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/13/2026 | 1.31 M | $39.10 M | 0.12% | 0.90% |
| TWO SIGMA INVESTMENTS, LP | 02/17/2026 | 1.06 M | $31.61 M | 19.17% | 0.73% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/17/2026 | 1.06 M | $31.49 M | 34.48% | 0.73% |
| CITADEL ADVISORS LLC | 02/17/2026 | 1.01 M | $30.14 M | 1.85% | 0.70% |
| JANE STREET GROUP, LLC | 02/12/2026 | 969.98 K | $28.91 M | -14.07% | 0.67% |
| MAN GROUP PLC | 02/17/2026 | 956.64 K | $28.52 M | -5.14% | 0.66% |
| NUVEEN, LLC | 02/12/2026 | 953.21 K | $28.42 M | 34.11% | 0.66% |
| BANK OF NEW YORK MELLON CORP | 02/10/2026 | 898.41 K | $26.78 M | 2.96% | 0.62% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/17/2026 | 887.45 K | $26.45 M | 25.29% | 0.61% |
| SQUAREPOINT OPS LLC | 02/13/2026 | 852.52 K | $25.41 M | 68.94% | 0.59% |
| BANK OF AMERICA CORP /DE/ | 02/17/2026 | 851.11 K | $25.37 M | 35.82% | 0.59% |
| PRINCIPAL FINANCIAL GROUP INC | 02/02/2026 | 847.79 K | $25.27 M | 8.11% | 0.58% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/17/2026 | 778.30 K | $23.20 M | -3.74% | 0.54% |
| EVENTIDE ASSET MANAGEMENT, LLC | 02/13/2026 | 716.41 K | $21.36 M | -24.95% | 0.49% |
| D. E. SHAW & CO., INC. | 02/17/2026 | 700.35 K | $20.88 M | 201.84% | 0.48% |
| JANE STREET GROUP, LLC | 02/12/2026 | 689.30 K | $20.55 M | 72.97% | 0.47% |
| BNP PARIBAS ARBITRAGE, SNC | 02/10/2026 | 683.65 K | $20.38 M | 856.64% | 0.47% |
| MILLENNIUM MANAGEMENT LLC | 02/17/2026 | 675.91 K | $20.15 M | 132.36% | 0.46% |
| RAYMOND JAMES FINANCIAL INC | 02/18/2026 | 629.95 K | $18.77 M | -6.55% | 0.43% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 02/17/2026 | 605.95 K | $18.06 M | -36.78% | 0.42% |
| TWO SIGMA ADVISERS, LP | 02/17/2026 | 599.60 K | $17.87 M | 40.03% | 0.41% |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | 02/17/2026 | 560.73 K | $16.72 M | 163.37% | 0.39% |
| PENN CAPITAL MANAGEMENT COMPANY, LLC | 02/09/2026 | 538.12 K | $16.08 M | 3.23% | 0.37% |
| UBS GROUP AG | 01/29/2026 | 537.02 K | $16.01 M | -13.14% | 0.37% |
| OPALEYE MANAGEMENT INC. | 04/13/2026 | 535.00 K | $15.95 M | 0.00% | 0.37% |
| TREXQUANT INVESTMENT LP | 02/17/2026 | 512.45 K | $15.28 M | 92.36% | 0.35% |
| BANK OF MONTREAL /CAN/ | 02/12/2026 | 512.38 K | $15.27 M | -0.05% | 0.35% |
| ALGERT GLOBAL LLC | 02/17/2026 | 485.19 K | $14.46 M | 489.03% | 0.33% |
| CITIGROUP INC | 02/13/2026 | 483.53 K | $14.41 M | -35.26% | 0.33% |
| DIMENSIONAL FUND ADVISORS LP | 02/12/2026 | 472.79 K | $14.09 M | 1,725.22% | 0.33% |
| PUBLIC SECTOR PENSION INVESTMENT BOARD | 02/13/2026 | 470.29 K | $14.02 M | -11.14% | 0.32% |
| BRIDGEWATER ASSOCIATES, LP | 02/13/2026 | 469.86 K | $14.01 M | 37.32% | 0.32% |
| BARCLAYS PLC | 02/13/2026 | 446.72 K | $13.32 M | -2.51% | 0.31% |
| VOYA INVESTMENT MANAGEMENT LLC | 02/12/2026 | 404.86 K | $12.07 M | 0.03% | 0.28% |
| 02/13/2026 | 401.60 K | $11.97 M | -1.95% | 0.28% | |
| WELLS FARGO & COMPANY/MN | 02/13/2026 | 395.68 K | $11.80 M | 45.11% | 0.27% |
| CITADEL ADVISORS LLC | 02/17/2026 | 385.80 K | $11.50 M | 5.76% | 0.27% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
TG Therapeutics Inc institutional Ownership - FAQ's
During the previous two years, 482 institutional investors and hedge funds held shares of TG Therapeutics Inc. The most heavily invested institutionals were:
CONGRESS ASSET MANAGEMENT CO /MA: 2.17 M
Pictet Asset Management Holding SA: 1.75 M
Nuveen, LLC: 1.45 M
Bank of New York Mellon Corp: 887,305
PRINCIPAL FINANCIAL GROUP INC: 665,526
Assenagon Asset Management S.A.: 510,054
70.91% of TG Therapeutics Inc stock is owned by institutional investors.
Institutional investors have bought a total of 125.70 M shares in the last 24 months. This purchase volume represents approximately $3.67 B in transactions.